The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells

The role of microenvironment and immunity in drug response in leukemia

(2016) Emyr Bakker et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Molecular pathogenesis of multiple myeloma

(2015) Yusuke Furukawa et al.   International Journal of Clinical Oncology

Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells

(2015) Masanobu Tsubaki et al.   LEUKEMIA RESEARCH

Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

(2015) Prahlad V. Raninga et al.   Oncotarget

miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14

(2014) Ning Wu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance

(2013) Z. Tian et al.   BLOOD

Over-Expression of Deubiquitinating Enzyme USP14 in Lung Adenocarcinoma Promotes Proliferation through the Accumulation of β-Catenin

(2013) Ning Wu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Overexpression of USP14 Protease Reduces I-κB Protein Levels and Increases Cytokine Release in Lung Epithelial Cells

(2013) Rachel K. Mialki et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications

(2013) C C Bjorklund et al.   LEUKEMIA

MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability

(2013) C Wan et al.   ONCOGENE

Overexpression of forkhead box J2 can decrease the migration of breast cancer cells

(2012) Yingying Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved  4 Integrin Expression and a Compromised CAM-DR Phenotype

(2011) M. F. Emmons et al.   MOLECULAR CANCER THERAPEUTICS